Late Phase Research Studies
“We support pharmaceutical companies to effectively meet the growing real-world data requirements with observational studies for better outcomes or greater value”
Our ethos is to encourage original scientific thought and innovation so that projects benefit from the best design and execution.
PRIMARY/ FIELD STUDIES
We work seamlessly with our partners to ensure that the specific requirements of real-world evidence are met in the most cost-effective way.
SECONDARY DATABASE STUDIES
We understand that matching research objectives with the capabilities of local data sources is an essential step in undertaking valid and credible research.
We combine elements of different study designs and data sources to maximise balance of validity, reliability, efficiency, costs and practicality and build a bespoke approach tailored to study objectives.
OXON offers single and multi-country primary data collection studies (Cohort, Case Control, Cross-Sectional and Surveys) using retrospective, prospective and cross-sectional data collection methodologies for safety, Market Access/HEOR and Drug Development.
OXON provides clients with single and multi-country database studies (Cohort, Case Control, Cross-Sectional) using secondary data sources to satisfy client’s requirements for safety, Market Access/HEOR and Drug Development.
OXON supports sponsors to fill evidence gaps and generate RWE through the most valid, reliable, efficient, cost-effective, and practical hybrid approaches. Our ability to combine data collection with secondary data allows an accurate approach to study objectives.
Observational Research Study Designs
OXON provides a unique blend of observational science and operational excellence to our clients as fellow scientists.
The objective of most clinical studies is to determine prevalence, incidence, cause, prognosis, or effect of treatment, being certain types of studies most commonly associated with each objective.
At OXON we advise clients frankly on the advantages and disadvantages of their observational study options while our experts help determine the right type of study according to the time, cost, and regulatory implications.
Patient registries provide a real-world view of clinical practice, patient and safety outcomes, comparative and cost-effectiveness, and serve to create evidence development and decision-making purposes.
OXON offers sponsors its expertise in pragmatic trials using data collection and secondary data sources to help bridge the gap between trials and real-world evidence for Safety and Market Access/HEOR.
We use a systematic approach to identify existing literature to appraise and synthesise the best available evidence on a defined question, and offer statistical approaches to combine the data derived from any systematic review.
PASS & PAES STUDIES
We assist our clients in designing and conducting post-authorisation safety/efficacy studies, always under the ENCePP guide on methodological standards in pharmacoepidemiology and Code of Conduct.
RISK MINIMISATION STUDIES
OXON delivers studies measuring the effectiveness of routine and additional risk minimization measures (RMMs) for products in most therapy areas and global risk minimisation approaches.
Expertise in health economics and patient-reported outcomes within observational studies to help collect the evidence needed to prove the cost-effectiveness & cost-utility of drugs required by stakeholders.